Current application of selective COX-2 inhibitors in cancer prevention and treatment.
MS Stratton, DS Alberts - Oncology (Williston Park, NY), 2002 - europepmc.org
The multistep process of carcinogenesis, which can take many years, provides many
opportunities for intervention to inhibit disease progression. Effective chemoprevention …
opportunities for intervention to inhibit disease progression. Effective chemoprevention …
Cyclooxygenase 2: a molecular target for cancer prevention and treatment
K Subbaramaiah, AJ Dannenberg - Trends in pharmacological sciences, 2003 - cell.com
Abstract Cyclooxygenase2 (COX-2), an inducible prostaglandin G/H synthase, is
overexpressed in several human cancers. Here, the potential utility of selective COX-2 …
overexpressed in several human cancers. Here, the potential utility of selective COX-2 …
Potential role of selective COX-2 inhibitors in cancer management.
CT Dang, CL Shapiro, CA Hudis - Oncology (Williston Park, NY), 2002 - europepmc.org
Tumorigenesis is a complex process, and understanding the mechanisms behind
tumorigenesis is key to identifying effective targeted therapies. Prostaglandins are signaling …
tumorigenesis is key to identifying effective targeted therapies. Prostaglandins are signaling …
A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer
LR Howe, AJ Dannenberg - Seminars in oncology, 2002 - Elsevier
Cyclooxygenase-2 (COX-2) is being intensively evaluated as a pharmacologic target for
both the prevention and treatment of cancer. Aberrant COX-2 expression was initially …
both the prevention and treatment of cancer. Aberrant COX-2 expression was initially …
Selective cyclooxygenase‐2 inhibition: a target in cancer prevention and treatment
S Subongkot, D Frame, W Leslie… - … : The Journal of Human …, 2003 - Wiley Online Library
A major goal in the area of cancer prevention and treatment is to make rational use of
defined molecular targets in order to block carcinogenesis. Studies conducted in …
defined molecular targets in order to block carcinogenesis. Studies conducted in …
COX-2 in cancer—a player that's defining the rules
ET Hawk, JL Viner, A Dannenberg… - Journal of the National …, 2002 - academic.oup.com
Cyclooxygenase (COX) inhibitors are being developed as potential agents for the
prevention and treatment of cancer after a century of widespread use for inflammation, fever …
prevention and treatment of cancer after a century of widespread use for inflammation, fever …
COX-2 inhibitors in cancer treatment and prevention, a recent development
XC Xu - Anti-cancer drugs, 2002 - journals.lww.com
Epidemiological and experimental studies have demonstrated the effect of non-steroidal anti-
inflammatory drugs (NSAIDs) in the prevention of human cancers. NSAIDs block …
inflammatory drugs (NSAIDs) in the prevention of human cancers. NSAIDs block …
Celecoxib: a specific COX-2 inhibitor with anticancer properties
AT Koki, JL Masferrer - Cancer control, 2002 - journals.sagepub.com
In addition to the well-established pathophysiological role that COX-2 plays in inflammation,
recent evidence implies that this isoform may also be involved in multiple biologic events …
recent evidence implies that this isoform may also be involved in multiple biologic events …
Cancer and the cyclo-oxygenase enzyme: implications for treatment and prevention
ET Hawk, JL Viner, A Umax, WF Anderson… - American Journal of …, 2003 - Springer
The cyclo-oxygenase (COX) metabolic pathway and prostaglandin (PG) production appear
to play a causal role in the promotion and progression of human cancers. COX-1 and COX-2 …
to play a causal role in the promotion and progression of human cancers. COX-1 and COX-2 …
[图书][B] COX-2 blockade in cancer prevention and therapy
RE Harris - 2002 - books.google.com
The revelation that aspirin and aspirin-like compounds have notableantineo plastic
properties has revolutionized cancer research. COX-2 Blockade in Cancer Prevention and …
properties has revolutionized cancer research. COX-2 Blockade in Cancer Prevention and …